The Procter & Gamble Company (PG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Oct, 2026Executive summary
Supplemental filing reaffirmed the Board’s recommendation to vote against Item 5 ahead of the October 13, 2026 annual meeting.
Voting matters and shareholder proposals
Item 5 asks the Board to preserve current Rule 14a-8 eligibility thresholds in annual proxy materials even if those thresholds later change; the Board recommends voting against it.
On September 16, 2026, the SEC proposed rescinding Rule 14a-8 in full; the proposal remains open to comment, may change or not be adopted, and could face litigation.
Board of directors and corporate governance
The Board favors retaining discretion to review the final legal framework and balance shareholder access, governance practices, administrative burdens, and long-term shareholder interests.
Partial view of Summaries dataset, powered by Quartr API
Latest events from The Procter & Gamble Company
- FY2026 growth and shareholder returns continued as execution priorities shifted to a changing market.PG
AGM 2026 - Execution, technology, and targeted interventions are driving growth and innovation across markets.PG
Barclays 19th Annual Global Consumer Conference - Board recommends director elections, auditor ratification, Say on Pay, and opposes all shareholder proposals.PG
Proxy filing - Director elections, auditor ratification, and key shareholder proposals headline the 2026 meeting.PG
Proxy filing - FY 2026 saw modest sales and EPS growth; FY 2027 guidance targets similar gains amid cost headwinds.PG
Q4 2026 - Stable markets, innovation focus, and organizational redesign drive future growth and agility.PG
Barclays 18th Annual Global Consumer Staples Conference 2025 - Organic sales and EPS grew in 2025; 2026 outlook calls for modest gains amid headwinds.PG
Q4 2025 - FY24 growth, innovation, and productivity drive strong returns and operational excellence.PG
Investor Day 2024 - Organic sales and core EPS grew, but net sales and diluted EPS declined on restructuring charges.PG
Q1 2025